Literature DB >> 3093568

BSF-1 action on resting B cells does not require elevation of inositol phospholipid metabolism or increased [Ca2+]i.

J Mizuguchi, M A Beaven, J Ohara, W E Paul.   

Abstract

B cell stimulatory factor-1 (BSF-1) acts on resting B cells to increase expression of class II major histocompatibility complex (MHC) molecules and to prepare for more prompt entry into S phase in response to anti-IgM and lipopolysaccharide. It also acts as a costimulant, with low concentrations of anti-IgM, to cause resting B cells to synthesize DNA. Unlike anti-IgM, BSF-1 does not cause elevation in inositol phospholipid metabolism or in concentration of intracellular free calcium, nor does it enhance such biochemical responses to anti-IgM. Furthermore, increased expression of class II MHC molecules to BSF-1 is observed when essentially all extracellular calcium is chelated by EGTA, whereas lower concentrations of EGTA completely inhibit increases in class II molecules in response to anti-IgM. These results indicate that BSF-1 effects on resting B cells are not mediated by the inositol phospholipid metabolic pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093568

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Increase in the intracellular free calcium concentration is not an obligatory early event in lipopeptide-induced B-cell activation.

Authors:  S Hauschildt; A Lückhoff; J Langhorne; K H Wiesmüller; G Jung; W Bessler; J C Cambier
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

3.  Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.

Authors:  R D Huby; G Janossy; I A Lampert
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  B-lymphocyte activation mediated by anti-immunoglobulin antibody in the absence of protein kinase C.

Authors:  J J Mond; N Feuerstein; F D Finkelman; F Huang; K P Huang; G Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

Authors:  A O'Garra; K P Rigley; M Holman; J B McLaughlin; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 6.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

7.  Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding.

Authors:  N Harada; B E Castle; D M Gorman; N Itoh; J Schreurs; R L Barrett; M Howard; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 8.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

9.  Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins.

Authors:  D A Shackelford; I S Trowbridge
Journal:  Cell Regul       Date:  1991-01

10.  Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells.

Authors:  J Mizuguchi; N Utsunomiya; M Nakanishi; Y Arata; H Fukazawa
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.